INTRODUCTION
The myocardial perfusion imaging report is the final product of a complicated process designed to produce high quality and valuable patient data. As such, it must contain sufficient information to convey the details of the procedure while simultaneously remaining succinct. The report should provide a basic ''bottom line'' result to the referring physician. [1] [2] [3] It should follow a defined structure and contain standardized data elements so that test results are portable as patients move through the healthcare system. The structured report is an integral part of the electronic health care record, and is necessary for defining quality in all nuclear cardiology practices. As the healthcare community moves away from open reporting, the implementation of structured reporting is expected to improve quality and outcomes and to reduce cost.
The myocardial perfusion imaging report is used for various purposes including patient care, research, quality assurance, reimbursement documentation, and incorporation of data into integrated imaging databases. The report may also be used by a variety of interested parties including physicians, researchers, insurers, and industry. To accommodate all of these functions and users, one should be able to rearrange the imaging report into multiple formats consisting of clear and defined structured data elements.
The appearance of the standardized report can, and should, vary from user to user. Report structure does not rely on a single standard appearance, but rather on the content and utilization of structured data elements. For example, one laboratory may choose to use a report that is formatted in paragraphs while another may use a tabular format, or even a combination of the two. All are structured reports as long as the data are derived from defined, structured data elements. 4, 5 Reports have limited utility if they cannot be used to communicate and transfer information from one source to another. The use of structured data and reporting, as defined by the Digital Imaging and Communications in Medicine (DICOM) standards and Integrating the Healthcare Enterprise (IHE) standards, allows this communication to occur. The DICOM standard for stress reporting includes the data elements for structured nuclear cardiology reporting. 6, 7 These elements have been adopted by developers and manufacturers of reporting software for clinical implementation. IHE has also published a standard for the communication of data among different vendor systems in single and multi-modality imaging environments. 8 The American College of Cardiology (ACC) has also published two relevant reporting documents. The ''Health Policy Statement on Structured Reporting in Cardiovascular Imaging'' 9 defines the generally accepted position of the cardiovascular community regarding structured reporting. The ''Key Data Elements and Definitions for Cardiac Imaging: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards'' 10 is designed to facilitate the reporting of imaging studies in multimodality environments by coordinating the definitions of some data elements used for myocardial perfusion and functional imaging. This has resulted in a ''redefinition'' of some of the data elements in prior versions of From Miriam Hospital, a Providence, RI; Emory University Hospital, the nuclear cardiology standard. This updated image reporting guideline incorporates and harmonizes these recommendations, unifies prior ASNC documents, and expands the imaging guidelines to include exercise and resting first-pass radionuclide angiography (FPRNA), equilibrium radionuclide angiocardiography (ERNA), positron emission tomography (PET), and viability imaging. This document will address both structured reports as well as structured data. Structured data elements will be reported in tables pertaining to each of the broad areas a structured report should contain. These tables consist of the variables, their description, format (i.e., text, numeric, date), priority (i.e., required, recommended, or optional), and allowed response(s). The structured reports portion of the document will discuss the use of the standard data elements to construct a report.
Due to considerable recent development and maturing of the tools required for widespread clinical implementation of structured reporting, the current document is an update of an earlier image reporting guideline that was developed by the American Society of Nuclear Cardiology (ASNC). 5 Given this significant degree of development, ASNC supports the mandatory use of structured reporting using standardized data elements in myocardial perfusion imaging reports. This should be implemented as part of the laboratory accreditation process.
This publication is designed to provide imaging guidelines for physicians and technologists who are qualified to practice nuclear cardiology. While the information supplied in this document has been carefully reviewed by experts in the field, the document should not be considered medical advice or a professional service.
STRUCTURED REPORTING

Components of the Report
According to the ''Health Policy Statement on Structured Reporting in Cardiovascular Imaging,'' 9 the standard components of a report include the following major headings: Administrative Information, Patient Demographics, Study Referral Data, History and Risk Factors, Study Description, Study Findings, and other reporting parameters. These elements are outlined in detail in ''Key Data Elements and Definitions for Cardiac Imaging: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards,'' 10 which addresses specific details for each of these major headings for multiple cardiac imaging modalities.
Table of Contents for Structured Data Elements
Site administrative data Table 1  Study demographics  Patient demographics  Table 2  Clinical information  Table 3  Stress testing data  Table 4  ECG data  Resting ECG data  Table 5  Stress ECG data  Table 6  Imaging data Imaging parameters Table 7  LV perfusion  Table 8  LV perfusion quantitation  Table 9  Stress LV function parameters  Table 10 Rest LV function parameters, if performed Table 11 Miscellaneous data Table 12  RV parameters  Table 13 FPRNA/ERNA (Rest and Exercise) specific variables Table 14 Viability-qualitative analysis Table 15  Viability-quantitative analysis  Table 16  Overall impression  Table 17 ECG, Electrocardiographic; LV, left ventricular; RV, right ventricular; FPRNA, first-pass radionuclide angiography; ERNA, equilibrium radionuclide angiocardiography.
A few of the general data elements, and many of the specific data elements, may be recorded at the time that the test is performed. Some elements may not be required in the final report. This may be the case for some fields that are required for quality reporting, but not necessarily for reporting the findings from an individual patient's study for specific patient management.
Many different structured reports can be generated from a set of structured data. The potential reports include: a clinical patient-specific report, summary quality report, billing report, and other reports as needed. The greatest strength to structured data utilization is the ability to generate multiple report formats with varying levels of detail depending on the clinical or administrative need. This document will harmonize these generalized concepts and apply them specifically to nuclear cardiology. Due to the variability of the study types encompassed by this document, some of the data elements are specific to certain types of acquisitions, or are dependent upon the study indication (e.g., viability determination by PET imaging). Therefore, some data elements may be required for certain acquisitions and clinical indications, while some may be optional and perhaps irrelevant for other indications.
A number of the data elements contained in the tables have been derived from, and harmonized with, other guideline documents, some multi-societal and others ASNC-specific. 2, [11] [12] [13] [14] [15] [16] This update also addresses additional modalities that were not included in the prior versions of the document, such as: PET, viability, FPRNA, and ERNA both at rest and with exercise. The data elements required for reporting the additional modalities have been added to specific tables where appropriate or additional tables have been added to the document to cover those items that were specific to the modality and could not be generalized to one of the existing table headings (Tables 14-16 ).
Site Administrative Data
The Site Administrative Data section of the report is the descriptor of the site performing the study. It includes elements such as the physical address, accreditation status, type of facility (e.g., hospital or office), and insurance payer. This data may only need to be collected as part of the reporting process, and some elements may not be recorded in the final report (Table 1) .
Patient Demographics and Study Referral
The Patient Demographics and Study Referral data section provides the clinical indications for the study. Major areas to be considered are: diagnosis of coronary artery disease (CAD), extent and severity of known CAD, risk stratification, determination of viability, and assessment of acute chest pain syndromes. With the inclusion of the History and Risk Factors section, this would complete the data elements contained in Tables 2 and 3. The specific purpose for which the test is being performed must be clearly identified. This provides the required documentation for the medical necessity of the study and its appropriateness, and focuses the report on the question asked by the referring physician. The structured data elements that relate to the indication can be located in Table 3 . The structured reports should contain sufficient information from these areas to ensure correct identification of the patient. The reports must also convey the specific indications for the study and the pertinent portions of the clinical history that allow the caregivers to appropriately place the imaging results in clinical context. This would include the patient's current symptoms or other indication for which the study is being performed, current medications, cardiac history with pertinent risk factors and prior testing, and therapeutic procedures. Tilkemeier et al Journal of Nuclear Cardiology ASNC imaging guidelines for nuclear cardiology procedures
Study Description
The Study Description should be the next section of the structured report. This section should include all of the parameters used in acquiring the study. It must include a description of the stress test performed, including the type of stress test (i.e., exercise or pharmacologic). For stress tests, it is necessary to include the type of protocol, duration of exercise, and its adequacy as determined by exercise time, peak heart rate, percent maximal predicted heart rate (MPHR), and estimated metabolic equivalents (METS). For pharmacologic stress tests, the pharmacologic agent used, the dose received, including the infusion rate and duration, hemodynamic response to the dose, and use of adjunctive exercise must be documented. The time of administration of radioactivity is also required for either modality. The specific data elements for this section as well as their responses can be found in Table 4 . The Electrocardiographic (ECG) Data pertinent to the test should be reported next. This would include the presence of any baseline ECG abnormalities that might preclude a conclusive interpretation of the ECG stress portion of the test (Table 5) . LBBB, Left bundle branch block; METS, metabolic equivalents; HR, heart rate; BPM, beats per minute; MPHR, maximal predicted heart rate; BP, blood pressure; ECG, electrocardiographic.
Tilkemeier et al
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The stress ECG interpretation must evaluate the parameters defined in Table 6 , commenting on any changes from baseline with regard to either the ST segments or onset of arrhythmias. Comparison to prior tests and inclusion of parameters that allow calculation of validated risk scores (e.g., the Duke treadmill score) 19 are recommended. The structured report format continues with variables that define the imaging process including the protocol utilized, the patient position, and radiopharmaceutical doses administered to the patient. It also includes their time of administration and whether attenuation correction or other modalities were used. These data elements are presented in detail in Table 7 .
The next data elements required for reporting are left ventricle (LV) perfusion parameters. Every perfusion defect must be quantified with regard to size (i.e., small, medium, and large), severity (i.e., mild, moderate, severe, and background), and type (i.e., reversible, persistent, and mixed). The location of the defect must be described using the standardized 17-segment model Journal 
. 11 The presence of apparent transient cavitary dilatation must be reported.
The remaining elements in Table 8 are recommended for use in reporting the LV perfusion parameters. The use of quantitative image processing is recommended for inclusion in the report and the suggested data elements to use when reporting quantitative elements are outlined in Table 9 . The information in these tables may be repeated as required to describe multiple perfusion defects. Optionally, LV volume data can be reported. The data elements specific to LV function are located in Tables 10 and 11 . The information in these tables may be repeated as required to describe multiple perfusion defects. The report must also function as part of the quality reporting mechanism for the lab. It must include a statement regarding the overall quality of the study and should address the presence of potential artifacts, incidental findings, and/or extra-cardiac activity that would be pertinent to or limit the quality of the study. These data elements are defined in Table 12 .
The perfusion imaging study can demonstrate perfusion data that allow interpretation of perfusion, size, and function of the right ventricle (RV). These may be optionally reported using the data elements in Table 13 . These are usually not routinely reported except in the presence of pathology or a specific indication that would warrant their inclusion in the report. The information in this table may be repeated as required to describe multiple perfusion defects. LV, Left ventricular; EF, ejection fraction; FPRNA, first-pass radionuclide angiography; ERNA, equilibrium radionuclide angiocardiography; EDV, end-diastolic volume; ESV, end-systolic volume; WT, wall thickening. 
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FPRNA and ERNA
FPRNA and ERNA utilize a number of variables included in other tables, such as those describing LV and RV function at rest and with exercise. A number of variables, however, are not covered adequately and are not assignable to other existing tables. Table 14 describes the variables that are specific for FPRNA and ERNA at rest or with exercise. 
Viability
Assessment of myocardial viability should include visual and quantitative analysis. Metabolism defects, perfusion/metabolism matched defects, and perfusion/ metabolism mismatched defects must be described with regard to location and size. [21] [22] [23] The remaining elements in Table 15 are recommended for use in reporting myocardial viability. The use of quantitative image elements (i.e., number of viable segments and extent of matched and mismatched defects) is also recommended. Table 16 outlines the quantitative data for myocardial viability.
The final component of the structured myocardial perfusion report is the most important. The Overall Impression assimilates all of the detailed findings presented in the prior sections into a succinct statement regarding whether LV perfusion and LV function are normal or abnormal and describes the abnormality as ischemia or infarction. It also addresses the presence or absence of significantly viable myocardium when this information is required.
Additionally, the Overall Impression summarizes the stress test findings, assesses the clinical significance of the scan, and may assign vascular territories to the abnormalities and compare results to prior studies. The data elements specific to this section are outlined in Table 17 .
Furthermore, to ensure timely access to the data, the report needs to be compliant with the standard for timely reporting requiring completion of the interpretation within one business day and transmittal from the lab to the referring physician within two business days. 24 The appendices to this guideline demonstrate model formats for structured reporting based on the principles and data elements contained in this document. Appendix 1 is a model format for stress myocardial perfusion imaging and Appendix 2 is a model format for pharmacologic-based myocardial perfusion imaging. They are intended as examples only and ASNC fully acknowledges that there are many allowable structured formats for the reporting of nuclear myocardial perfusion images. Different structured report formats would The patient performed treadmill exercise/bicycle exercise using a modified Bruce/Bruce/Naughton/ ____ protocol, completing ____ minutes and completing an estimated workload of ____ metabolic equivalents (METS). The test was terminated due to fatigue/shortness of breath/chest pain/___. The heart rate was ____ beats per minute at baseline and increased to ____ beats at peak exercise, which was ____% of the maximum predicted heart rate. The rest blood pressure was ___ mm/Hg and increased/ decreased to ___ mm/Hg, which is a normal/ hypotensive/hypertensive response. The patient did/ did not develop any symptoms other than fatigue during the procedure; specific symptoms include ____. The resting electrocardiogram demonstrated ____ and did/did not show ST-segment changes consistent with myocardial ischemia.
Myocardial perfusion imaging was performed at rest (____ minutes following the injection of ____ mCi of ____). At peak exercise, the patient was injected with ____ mCi of ____ and exercise was continued for ____ minute(s). Gating post-stress tomographic imaging was performed ____ minutes after stress (and rest).
Findings
The overall quality of the study is poor/fair/good/ excellent. Attenuation artifact was present/absent. Left ventricular cavity is noted to be normal/ enlarged on the rest (and/or stress) studies. There is evidence of abnormal lung activity. Additionally, the right ventricle is normal/abnormal (specify: ____).
SPECT images demonstrate homogeneous tracer distribution throughout the myocardium OR a small/ moderate/large perfusion abnormality of mild/moderate/severe severity is present in the ____ (location) region on the stress images. The rest images reveal ____. Gated SPECT imaging reveals normal myocardial thickening and wall motion. OR Gated SPECT imaging demonstrates hypokinesis/dyskinesis/akinesis of the ____ (location). The left ventricular ejection fraction was calculated to be ____% OR the left ventricular ejection fraction was normal ([;60%).
Impression
Myocardial perfusion imaging is normal/abnormal. There is a small/moderate/large area of ischemia/ infarction in the ____ location. Overall left ventricular systolic function was normal/abnormal with/ without regional wall motion abnormalities (as noted above). Compared to the prior study from ____ (date), the current study reveals ____. Pharmacologic stress testing was performed with adenosine/dipyridamole/dobutamine/regadenoson at a rate of ____ for ___minutes. Additionally, lowlevel exercise was performed along with the vasodilator infusion (specify: ____). The heart rate was ____ at baseline and rose to ____ beats per minute during the adenosine/dipyridamole/dobutamine/regadenoson infusion. The rest blood pressure was ___ mm/Hg and increased/decreased to ___ mm/Hg, which is a normal/hypotensive/hypertensive response. The patient developed significant symptoms, which included ____. The resting electrocardiogram demonstrated ____ and did/did not show ST-segment changes consistent with myocardial ischemia.
Myocardial perfusion imaging was performed at rest (____ minutes following the injection of ____ mCi of ____). At peak pharmacologic effect, the patient was injected with ____ mCi of ____. Gating poststress tomographic imaging was performed ____ minutes after stress (and rest).
Findings
SPECT images demonstrate homogeneous tracer distribution throughout the myocardium OR a small/ moderate/large perfusion abnormality of mild/moderate/severe severity is present in the ____ (location) region on the stress images. The rest images reveal ____. Gated SPECT imaging reveals normal myocardial thickening and wall motion. OR Gated SPECT imaging demonstrates hypokinesis/dyskinesis/akinesis of the ____ (location). The left ventricular ejection fraction was calculated to be ____% OR the left ventricular ejection fraction was normal ([60%).
Impression
Myocardial perfusion imaging is normal/abnormal. There is a small/moderate/large area of ischemia/ infarction in the ____ location. Overall left ventricular systolic function was normal/abnormal with/without regional wall motion abnormalities (as noted above). Compared to the prior study from ____ (date), the current study reveals ____.
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